News

Almirall Completes Regulatory Approval for Efinaconazole in Europe

Almirall Completes Regulatory Approval for Efinaconazole in Europe

Almirall Celebrates Major Milestone in Regulatory Approval

Almirall, S.A. (ALM), a prominent global pharmaceutical company focused on medical dermatology, has proudly announced that it has completed the decentralized regulatory procedure for efinaconazole in Europe. This triazole antifungal compound is specifically designed to treat onychomycosis, a nail fungal infection, marketed under the name Jublia.

Understanding Onychomycosis and Its Impact

Onychomycosis is a widespread issue, affecting around 5.5% of the global population. This condition is responsible for approximately 50% of all nail disorder appointments. Regarded as a persistent and hard-to-treat ailment, onychomycosis often poses challenges in achieving successful long-term treatment due to adherence issues. Efinaconazole's unique properties, particularly its high nail-penetrating capabilities and binding affinity to keratin, make it an effective topical treatment.

Enhancing the Dermatology Portfolio

The approval of efinaconazole in Europe complements Almirall's existing portfolio in medical dermatology, reinforcing the company’s dedication to improving the lives of those dealing with skin infections. Almirall strives to provide dermatologists and patients with innovative treatment options that create a significant impact.

Commitment from Almirall Leadership

Dr. Karl Ziegelbauer, Almirall's Executive VP of R&D and CSO, emphasized the company's mission: "At Almirall, we are committed to addressing the unmet needs of individuals with persistent skin conditions. The approval of efinaconazole signifies a substantial advancement in our onychomycosis treatment offerings, and we are eager to make this therapy available to dermatologists across Europe soon."

Strategic Partnerships and Future Prospects

In a significant development back in July 2021, Almirall entered a license and distribution agreement with Kaken. This agreement grants Almirall exclusive rights to develop and market efinaconazole in Europe, thereby solidifying their position in the dermatology market.

Global Recognition of Efinaconazole

The product has been available in Japan since 2014, where it is marketed under the trade name Clenafin. It has also seen a successful launch in the United States, Canada, Korea, Hong Kong, and Macau, under the Jublia brand, thanks to Kaken Pharmaceutical’s partners.

Looking Towards Regulatory Approval in Europe

The completion of the decentralized regulatory procedure represents a pivotal step towards acquiring national marketing authorizations across various European countries. Almirall is currently collaborating with national regulatory authorities, with marketing authorizations anticipated within the first half of the year 2025.

About Almirall and Its Vision

Almirall is a trailblazer in the field of medical dermatology, consistently working with leading scientists, healthcare professionals, and patients. The company’s mission is to transform patients' lives by bringing their aspirations for health to reality. With a focus on innovative and differentiated medical dermatology products, Almirall is dedicated to meeting the needs of patients worldwide.

Founded in 1944 and headquartered in Barcelona, Almirall is publicly listed on the Spanish Stock Exchange (ticker: ALM). The company reported total revenues of €898.8 million in 2023 and employs approximately 1,900 individuals globally. Almirall is committed to enhancing the quality of life for patients, offering solutions in over 100 countries.

Frequently Asked Questions

What is efinaconazole used to treat?

Efinaconazole is used to treat onychomycosis, a fungal infection of the nails.

When is efinaconazole expected to be available in Europe?

Marketing authorizations for efinaconazole are anticipated within the first half of 2025.

What are the unique properties of efinaconazole?

Efinaconazole has high nail-penetrating properties and a strong binding affinity to keratin, enhancing treatment efficacy.

What commitment does Almirall have towards dermatology?

Almirall is dedicated to medical dermatology and aims to provide innovative treatment options for those with skin conditions.

In how many countries does Almirall operate?

Almirall products are available in over 100 countries worldwide.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

NaLA Pushes for Stronger Lifeline Fraud Measures

Updated Category News Views 79

Here's the thing about the Lifeline program: it's meant to be a lifeline, not a loophole for the crafty and unscrupulous. The National Lifeline Association (NaLA) is slamming the table, demanding that the Senate Commerce Committee put some real muscle into preventing fraud. Why the Urgency on Lifeline Fraud? NaLA’s got its sights on a more robust defensive line against...

Continue Reading
League's AI Launch: A New Era in Healthcare

Updated Category News Views 76

AI: Healthcare's Bold New Move Ah, here we go. Another tech jump in healthcare. This time it's the folks over at League, stirring the pot with some new AI gimmicks. They've slapped together what they call an 'AI Front Door' and an 'AI Care Companion'—part of their Forge by League platform. Now, if there's one thing we know, it's that the healthcare sector loves a good...

Continue Reading
Wall Street Gains Hold Amid Volatility Drop

Updated Category News Views 24

A Week of Gains and Regulatory Moves Right out of the gate, it’s been a decent stretch for Wall Street. Weekly gains kept the party going, even as traders navigated the usual hurdles. Stocks finished the week with a solid performance—all the heavy hitters like Dow, S&P 500, Nasdaq, and Russell 2000 ended on a high note, waltzing uphill past where many imagined...

Continue Reading
Painter's Accessory Aims to Revolutionize Convenience

Updated Category News Views 73

Crafty New Invention Targets Painters' Ease Ever find yourself tangled in paintbrushes and rollers while trying to get that perfect coat on the wall? Well, a painter from Bracebridge, Ontario, has had it with the struggle and is looking to stir the pot with their latest invention, the NU LIFE LINER. It's sleek, it's practical, and it's aimed at flipping the painting game...

Continue Reading
S&P Global's Bold $2 Billion Debt Offering Details

Updated Category News Views 80

Drilling Down into S&P Global's Debt Move S&P Global's throwing its hat in the ring with a colossal $2 billion debt offering. Now, they aren't just setting it on the table — they're notably carving it up into three chunks. You’ve got $750 million at 5.600% that comes due in 2031, $600 million at 5.800% for 2034, and $650 million at a 6.000% rate maturing in 2036....

Continue Reading
Hermes AI: A New Era in Market Analysis?

Updated Category News Views 88

Revolution or Just Another App? In a world where stock market insights are as cryptic as hieroglyphs to the average Joe, here comes the Hermes AI Analyzer, breaking onto the scene and promising to translate Wall Street's complex lingo into plain, simple language. It's the brainchild of Turkish engineer Umut Tugrul, who has spent decades in the trenches of software...

Continue Reading
GALC Launches Tender Offer on 2027 Notes Amid Debt Play

Updated Category News Views 70

Aviation Leasing Giant's Strategic Financial Move Well folks, we're staring down the barrel of a financial maneuver by Global Aircraft Leasing Co., Ltd. (GALC) that’s not just another day at the office. They've kicked off a cash tender offer for their 8.750% Senior Secured Notes due 2027, aiming to sweep up any and all outstanding ones. That's $932 million in principle...

Continue Reading
Rock & Roll Hall of Fame's 2026 Induction Triumph

Updated Category News Views 158

A Night of Unstoppable Talent The Rock & Roll Hall of Fame's 2026 Induction Ceremony and boy, what a spectacle it was. Held on a lively Saturday night, November 14, in Los Angeles, it wasn't just an event; it was an electrifying testament to music's profound impact. With the grand ceremony kicking off at the historic city of stars, this year's induction turned the dial to...

Continue Reading
Québecor Makes Its Move: Eye on TELUS Amid Telecom Shakeup

Updated Category News Views 110

The Offer That Shocked the Telecom Markets Just when you think you’ve figured out the lay of the land, someone throws a curveball. Québecor’s decision to take a run at TELUS is shaking up Canada’s telecom scene big time. This isn’t just another M&A whisper; it’s a roaring freight train of a proposal valued at a whopping $31 billion. And TELUS, not just sitting...

Continue Reading
Lennar Faces Legal Heat Over Alleged Misleading Statements

Updated Category News Views 120

Rumbling Legal Drama with Lennar Corporation Every trader knows the uneasy feeling when a stock you're eyeing takes a surprising nosedive on some legal muck coming out of the woodwork. Well, it's Lennar Corporation's turn in the spotlight for all the wrong reasons. They're getting slapped with a class action lawsuit by investors claiming the company pulled a fast one...

Continue Reading

Top 5 Most Recently Viewed Articles

BriteCap Financial Achieves Major Funding Milestone

Updated Category News Views 124

BriteCap Financial Achieves Major Funding Milestone BriteCap Financial, a leading small business funding platform, has proudly announced that it has surpassed $1 billion in total originations since its inception. This impressive milestone was achieved in late 2025, highlighting a year of remarkable growth and success for the company. Record Growth in 2025 The achievement...

Continue Reading
Aker Horizons ASA's Upcoming Virtual Annual Meeting Details

Updated Category News Views 261

Aker Horizons ASA Announces Details of Virtual Annual Meeting Aker Horizons ASA, a key player in green energy solutions, has scheduled its annual general meeting to take place online. This digital event will allow shareholders to engage and participate from any location, enhancing accessibility for all stakeholders. Details on the Virtual Meeting The annual general...

Continue Reading
Integrated Analytical Solutions Opens New Cannabis Lab Facility

Updated Category News Views 165

Integrated Analytical Solutions Launches a New Cannabis Testing Facility Integrated Analytical Solutions (IAS), renowned for its analytical testing services, is making strides in the cannabis industry with the grand opening of its state-of-the-art cannabis testing laboratory. This facility is a significant addition to services aimed at promoting safety, quality, and...

Continue Reading
Trip.com Group Files 2024 Annual Report with SEC Insights

Updated Category News Views 1309

Trip.com Group Limited Files Annual Report on Form 20-F Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) has announced the submission of its annual report on Form 20-F. This report includes the company's audited financial statements covering the three years leading up to December 31, 2024, presented to the Securities and Exchange Commission. The filing was made recently...

Continue Reading
Revolutionizing Pediatric Healthcare: Office Practicum's Portal

Updated Category News Views 254

Transforming Pediatric Healthcare with an Innovative Portal Office Practicum is leading the charge in pediatric care by introducing a state-of-the-art Patient Portal, created in partnership with BridgeInteract. This comprehensive tool has been tailored specifically for pediatric practices, presenting a modern and user-friendly platform that serves both families and...

Continue Reading